15-41850869-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016642.4(SPTBN5):c.10906C>G(p.Leu3636Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 1,447,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016642.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTBN5 | NM_016642.4 | c.10906C>G | p.Leu3636Val | missense_variant | Exon 66 of 68 | ENST00000320955.8 | NP_057726.4 | |
SPTBN5 | XM_017022299.2 | c.11086C>G | p.Leu3696Val | missense_variant | Exon 64 of 66 | XP_016877788.1 | ||
SPTBN5 | XM_017022302.2 | c.8263C>G | p.Leu2755Val | missense_variant | Exon 52 of 54 | XP_016877791.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1447634Hom.: 0 Cov.: 30 AF XY: 0.00000557 AC XY: 4AN XY: 718678
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.10801C>G (p.L3601V) alteration is located in exon 66 (coding exon 65) of the SPTBN5 gene. This alteration results from a C to G substitution at nucleotide position 10801, causing the leucine (L) at amino acid position 3601 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.